Kader, S. (2017) “Comparative Study between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients”, Iraqi Journal of Pharmaceutical Sciences, 18(2), pp. 32–38. doi:10.31351/vol18iss2pp32-38.